Insulin glargine (Lantus)

DRUG4 trials

Sponsors

Daiichi Sankyo, Pfizer, Sanofi

Conditions

AMIDiabetes Mellitus, Type 2Type 2 Diabetes

Phase 2

Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes

CompletedNCT00147745

Daiichi SankyoType 2 Diabetes

Start: 2005-06-30End: 2008-01-31Updated: 2014-04-02

Phase 3

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction

TerminatedNCT00670228

Start: 2008-04-30End: 2009-11-30Updated: 2011-02-11

Phase 4

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

CompletedNCT00367445

PfizerDiabetes Mellitus, Type 2

Start: 2006-09-30End: 2007-02-28Target: 30Updated: 2008-01-29

Unknown Phase

LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus

CompletedNCT00423215

SanofiDiabetes Mellitus, Type 2

Start: 2006-03-31End: 2008-05-31Updated: 2009-06-15